Biotech Analyst at Morgan Stanley Tactical Value
Michael Aberman, M.D.
Michael Aberman, M.D. joined Regeneron in 2010 as Vice President, Strategy and Investor Relations. Prior to joining Regeneron, Dr. Aberman w...